BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lundt S, Ding S. NAD+ Metabolism and Diseases with Motor Dysfunction. Genes (Basel) 2021;12:1776. [PMID: 34828382 DOI: 10.3390/genes12111776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Qin Y, Chen Z, Wu J, Zhang Z, Yuan Z, Guo D, Chen M, Li X, Yuan F. Circadian clock genes as promising therapeutic targets for bone loss. Biomedicine & Pharmacotherapy 2023;157:114019. [DOI: 10.1016/j.biopha.2022.114019] [Reference Citation Analysis]
2 Huang J, Gao M, Li D, Zhan S, Qiu Y, Chen B, Cao T, Chen Z. Nicotinic acid protected germinal vesicle oocyte meiosis against toxicity of benzo(a)pyrene during maturation.. [DOI: 10.21203/rs.3.rs-2236225/v1] [Reference Citation Analysis]
3 Larrea D, Tamucci KA, Kabra K, Velasco KR, Yun TD, Pera M, Montesinos J, Agrawal RR, Smerdon JW, Lowry ER, Stepanova A, Yoval-sanchez B, Galkin A, Wichterle H, Area-gomez E. Altered MAM function shifts mitochondrial metabolism in SOD1-mutant models of ALS.. [DOI: 10.1101/2022.09.22.508778] [Reference Citation Analysis]
4 Zhu Y, Xu P, Huang X, Shuai W, Liu L, Zhang S, Zhao R, Hu X, Wang G. From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases. Front Pharmacol 2022;13:920113. [DOI: 10.3389/fphar.2022.920113] [Reference Citation Analysis]